bpc 157 peptide for injury BPC-157 vs TB-500: Complete Comparison (2026) BPC-157 – Research Peptide |

Across all of it, he keeps returning to one frame: peptides are amino acid sequences the body recognises, not drugs in the conventional sense

Week 29 onward: Retatrutide 8-12 mg weekly + Cagrilintide 2.0-2.4 mg weekly

High cortisol can also cause sugar cravings

Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially filling in for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness